Antifolate antimalarial resistance in southeast Africa: A population-based analysis

Lancet

Volumn 361, Issue 9364, 2003, Pages 1174-1181

  Roper, Cally ^a   Pearce, Richard ^a   Bredenkamp, Barry ^b   Gumede, Jonathan ^c   Drakeley, Chris ^a,d   Mosha, Frank ^d   Chandramohan, Daniel ^a   Sharp, Brian ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c DEPARTMENT OF HEALTH   (South Africa)

^d KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; FOLIC ACID ANTAGONIST; MICROSATELLITE DNA;

ADULT; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; DNA FLANKING REGION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MOLECULAR EVOLUTION; PLASMODIUM FALCIPARUM; POLYMORPHIC LOCUS; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTOZOAL GENETICS; SOUTH AFRICA; TANZANIA;

EID: 0037420464     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12951-0     Document Type: Article

References (29)

1. Marsh K. Malaria disaster in Africa. Lancet. 352:1998;924.
2. Wang P., Lee C.-S., Bayoumi R., et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol. 89:1997;161-177.
3. Sims P., Wang P., Hyde J.E. On "The efficacy of antifolate antimalarial combinations in Africa" Parasitology Today. 14:1998;136-137.
4. Hastings I.M., Watkins W.M., White N.J. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc London Ser B. 357:2002;505-519.
5. Wu Y., Kirkman L.A., Wellems T.E. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci USA. 93:1996;1130-1134.
6. Triglia T., Menting J.G.T., Wilson C., Cowman A.F. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA. 94:1997;13944-13949.
7. Triglia T., Wang P., Sims P.F.G., Hyde J.E., Cowman A.F. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J. 17:1998;3807-3815.
8. Omar S.A., Adagu I.S., Warhurst D.C. Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Trans R Soc Trop Med Hyg. 95:2001;315-319.
9. Kublin J.K., Dzinjalamala F.K., Kamwendo D.D., et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 185:2002;380-388.
10. Paget-McNichol A., Saul A. Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. Parasitology. 1122:2002;497-505.
11. White N.J., Nosten F., Looareesuwan S., et al. Averting a malaria disaster. Lancet. 353:1999;1965-1967.
12. Wootton J.C., Feng X., Ferdig M.T., et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 417:2002;320-323.
13. Bredenkamp B.L., Sharp B.L., Mthembu S.D., Durrheim D.N., Barnes K.I. Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal. S Afr Med J. 91:2001;970-972.
14. Pearce R.J., Drakeley C., Chandramohan D., Mosha F., Roper C. Molecular determination of point mutation haplotypes in the dhfr and dhps of P falciparum in three regions of northern Tanzania. Antimicrob Agents Chemother. 47:2003;1347-1357.
15. Bahl A., Brunk B., Coppel R.L., et al. PlasmoDB: the Plasmodium genome resource. An integrated database providing tools for accessing, analysing and mapping expression and sequence data (both finished and unfinished). Nucleic Acids Res. 30:2002;87-90.
16. Su X., Wellems T.E. Toward a high resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. Genomics. 33:1996;430-444.
17. Hartl D.L., Clark A.G. Principles of population genetics. 3rd edn:1997;430-444 Sinauer Associates, Sunderland, MA.
18. Mberu E.K., Mosobo M.K., Nzila A.M., Kokwaro G.O., Sibley C.H., Watkins W.M. The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi Kenya. Am J Trop Med Hyg. 62:2000;396-401.
19. Nzila A.M., Nduati E., Mberu E.K., et al. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. J Infect Dis. 181:2000;2023-2028.
20. Curtis J., Duraisingh M.T., Warhurst D.C. In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sufadoxine but not chlorproguanil-dapsone treatment. J Infect Dis. 177:1998;1429-1433.
21. Plowe C.V., Cortese J.F., Djimde A., et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine sulfadoxine use and resistance. J Infect Dis. 176:1997;1590-1596.
22. Cowman A.F., Morry M.J., Biggs B.A., Cross G.A., Foote S.J. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA. 85:1998;9109-9113.
23. Peterson D.S., Walliker D., Wellems T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA. 85:1988;9114-9118.
24. Su X., Kirkman L.A., Fujioka H., Wellems T.E. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine resistant P falciparum in Southeast Asia and Africa. Cell. 91:1997;593-603.
25. Cortese J.F., Caraballo A., Contreras C.E., Plowe C.V. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Inf Dis. 186:2002;999-1006.
26. Kublin J.G., Witzig R.S., Shankar A.H. Molecular assays for surveillance of antifolate-resistant malaria. Lancet. 351:1998;1629-1630.
27. Clyde D. Malaria in Tanzania. 1967;Oxford University Press, Oxford, UK.
28. Avery Jones S. Mass treatment with pyrimethamine: a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya Sept, 1952-Sept, 1953. Trans R Soc Trop Med Hyg. 52:1958;547-561.
29. Payne D. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? Parasitol Today. 4:1988;112-115.